AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca interest and dividends income ($) ($)
Form 11-K Statements of Changes in Net Assets
Latest, FY2025
20,806,106
Period ended Dec 31, 2025
Change on a year earlier
-4.7%
21,840,086 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Interest and dividends income ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20,806,106 | -4.7% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2024 | Dec 31, 2024 | 21,840,086 | -1.3% | Form 11-K FY2024 (AstraZeneca US 401(k) Plan) ↗ |
| FY2023 | Dec 31, 2023 | 22,120,386 | +57.8% | Form 11-K FY2023 (AstraZeneca US 401(k) Plan) ↗ |
| FY2022 | Dec 31, 2022 | 14,017,821 | +6.6% | Form 11-K FY2022 (AstraZeneca US 401(k) Plan) ↗ |
| FY2021 | Dec 31, 2021 | 13,150,069 | -77.7% | Form 11-K FY2021 (AstraZeneca US 401(k) Plan) ↗ |
| FY2020 | Dec 31, 2020 | 58,995,355 | – | Form 11-K FY2020 (AstraZeneca US 401(k) Plan) ↗ |
Cite this data
StockData. (2026). AstraZeneca Interest and dividends income ($) ($), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/plan11k_div_interest
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.